First Appeared on 12/31/2007 |
| VAERS ID: |
281655
|
Vaccinated: |
2007-01-01 |
| Age: |
70.0 |
Onset: |
2007-01-01 |
| Gender: |
Female |
Submitted: |
2007-06-13 |
| Location: |
Nebraska |
Entered: |
2007-06-14 |
|
| Life Threatening? No |
| Died? No |
| Permanent Disability? Yes |
| Recovered? No |
| ER or Doctor Visit? Yes |
| Hospitalized? No |
| Previous Vaccinations: |
| Other Medications: Unknown |
| Current Illness: |
| Preexisting Conditions: Unknown |
| Diagnostic Lab Data: Unknown |
| CDC 'Split Type': |
|
| Vaccination |
Manufacturer |
Lot |
Dose |
Route |
Site |
| VARZOS: ZOSTER (ZOSTAVAX) |
MERCK & CO. INC. |
|
|
UN |
UN |
|
| Administered by: Other
Purchased by: Unknown |
| Symptoms: Pain, Rash vesicular |
| Write-up: Information has been received from a physician concerning a female patient in her 70''''s who in 2007 was vaccinated with a 0.65 ml dose of Zostavax. Subsequently /"recently/" in 2007, the patient developed a zoster-like rash and alot of pain all over. Unsp"ecified medical attention was sought. At the time of the report, the patient had not recovered. There was no product quality complaint involved. The physician considered the patient''''s experiences to be disabling. Additional information has been requested |
|
|
Changed on 12/8/2009 |
| VAERS ID: |
281655 Before
After
|
Vaccinated: |
2007-01-01 |
| Age: |
70.0 |
Onset: |
2007-01-01 |
| Gender: |
Female |
Submitted: |
2007-06-13 |
| Location: |
Nebraska |
Entered: |
2007-06-14 |
|
| Life Threatening? No |
| Died? No |
| Permanent Disability? Yes |
| Recovered? No/No |
| ER or Doctor Visit? Yes |
| Hospitalized? No |
| Previous Vaccinations: |
| Other Medications: Unknown |
| Current Illness: |
| Preexisting Conditions: Unknown |
| Diagnostic Lab Data: Unknown |
CDC 'Split Type':
(blank)
WAES0706USA00108 |
|
| Vaccination |
Manufacturer |
Lot |
Dose |
Route |
Site |
| VARZOS: ZOSTER (ZOSTAVAX) |
MERCK & CO. INC. |
|
|
UN |
UN |
|
| Administered by: Other
Purchased by: Unknown/Other |
| Symptoms: Pain, Rash vesicular |
Write-up:
Information has been received from a physician concerning a female patient in her 70''''s 70''s who in 2007 was vaccinated with a 0.65 ml dose of Zostavax. Subsequently /"recently/" "recently" in 2007, the patient developed a zoster-like rash and alot of pain all over. Unsp"ecified Unspecified medical attention was sought. At the time of the report, the patient had not recovered. There was no product quality complaint involved. The physician considered the patient''''s patient''s experiences to be disabling. Additional information has been requested requested.
|
|
|
